Phenoxybenzamine is a potent, long-acting alpha-adrenergic antagonist specifically indicated for the management of hypertensive episodes and autonomic dysfunction associated with pheochromocytoma. By facilitating a non-competitive and irreversible blockade of both alpha-1 and alpha-2 receptors, the medication provides a therapeutic synergy that effectively neutralizes excessive catecholamine activity to ensure sustained hemodynamic stability. The capsule delivery system allows for precise oral titration and consistent bioavailability, providing a controlled pharmacological profile that is essential for both pre-operative stabilization and chronic symptomatic control.

Reviews
There are no reviews yet.